Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks
In This Article:
As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor concerns.
Oops, something went wrong
As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor concerns.
Try again.